Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|September 14, 2012
Proteomics approaches for myeloid leukemia drug discoveryIsha Kapoor, Pooja Pal, Savita Lochab, et al.
Plos One|June 14, 2013
E3 ubiquitin ligase E6AP negatively regulates adipogenesis by downregulating proadipogenic factor C/EBPalphaPooja Pal, Savita Lochab, Jitendra Kumar Kanaujiya, et al.
Biochimica Et Biophysica Acta|July 4, 2013
E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradationSavita Lochab, Pooja Pal, Isha Kapoor, et al.
Electrophoresis|January 22, 2011
Proteomic approaches in myeloid leukemiaJitendra Kumar Kanaujiya, Savita Lochab, Pooja Pal, et al.
Proteomics|April 12, 2013
Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cellsJitendra Kumar Kanaujiya, Savita Lochab, Isha Kapoor, et al.
The Journal of Biological Chemistry|November 7, 2015
E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for DegradationYogesh Kumar, Isha Kapoor, Kainat Khan, et al.
Free Radical Biology & Medicine|February 17, 2018
BMP signaling-driven osteogenesis is critically dependent on Prdx-1 expression-mediated maintenance of chondrocyte prehypetrophyYogesh Kumar, Tathagata Biswas, Gatha Thacker, et al.
Biochimica Et Biophysica Acta|January 19, 2016
Skp2 inhibits osteogenesis by promoting ubiquitin-proteasome degradation of Runx2Gatha Thacker, Yogesh Kumar, Mohd Parvez Khan, et al.
European Journal of Medicinal Chemistry|March 9, 2010
Synthesis and cytotoxicity evaluation of (tetrahydro-beta-carboline)-1,3,5-triazine hybrids as anticancer agentsRavi Kumar, Leena Gupta, Pooja Pal, et al.
Pageof 1